The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization.
暂无分享,去创建一个
[1] Marco Cavaco,et al. Peptibodies: An elegant solution for a long‐standing problem , 2018, Biopolymers.
[2] R. Hoffmann,et al. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum , 2017, PloS one.
[3] W. S. Horne,et al. Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution , 2016, Chembiochem : a European journal of chemical biology.
[4] Andy Chi-Lung Lee,et al. A Comprehensive Review on Current Advances in Peptide Drug Development and Design , 2019, International journal of molecular sciences.
[5] A. Gautam,et al. THPdb: Database of FDA-approved peptide and protein therapeutics , 2017, PloS one.
[6] T. Hoffmann,et al. Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.